Qmiiz ODT - An Orally Disintegrating Meloxicam Tablet

Date: September 23, 2019
Issue #: 
1581Summary: 
The FDA has approvedQmiiz ODT (TerSera), an orally
disintegrating tablet formulation of the prescription
NSAID meloxicam.Qmiiz ODT, like conventional oral
meloxicam tablets (Mobic, and generics), is indicated
for relief of the symptoms of osteoarthritis (OA) and
rheumatoid arthritis (RA) in adults and of juvenile RA
in children who weigh≥60 kg.Vivlodex, a low-dose
capsule formulation of meloxicam, is FDA-approved
only for management of OA pain.

Source: The Medical Letter - August 6, 2019 Category: Drugs & Pharmacology Authors: admin Tags: Meloxicam Mobic NSAIDs Osteoarthritis Qmiiz ODT Rheumatoid arthritis Vivlodex Source Type: research